A trailblazing physician-scientist, Tavazoie has substantially expanded our understanding of the mechanisms enabling some tumors to spread from one body site to another. He is the 18th member of Rockefeller’s faculty elected to the academy.
Through questioning their assumptions about how mosquitoes sense and interpret odors, scientists may have discovered why efforts to throw the vectors of dengue and Zika off the human scent have not succeeded.
After gracing the university’s north-south pathway for decades, a London plane tree was cut down due to interior decay and the resulting safety risk. Removal of the deciduous giant required a team of highly-experienced arborists.
How did songbirds start singing? Neuroscientists are reshaping our understanding of speech—pinpointing the cells and molecules that built it and what happens in the brain when we learn a new word, chirp, or squeal.
With a new portrait by artist Brenda Zlamany, installed over the fireplace in the Abby Aldrich Rockefeller Reception Hall, the likenesses of scientists Marie Daly, Rebecca Lancefield, Louise Pearce, Gertrude Perlmann, and Florence Sabin have joined the university’s art collection.
With this week’s ceremony, the first in-person convocation since the start of the pandemic, Rockefeller has granted doctor of philosophy degrees in bioscience to 1,395 students. In addition, Anthony S. Fauci, Katalin Karikó, and Lulu C. Wang received honorary doctor of science degrees.
Linker histone H1 appears capable of distinguishing between single-stranded and double-stranded DNA, suggesting that its role in maintaining our genomes extends far beyond that of keeping chromosomes compact.
The compound attacks MRSA, C. diff, and several other deadly pathogens. Its discovery demonstrates the power of combining computational biology, genetic sequencing, and synthetic chemistry to study bacterial evolution.
A new study reveals how the drug fidaxomicin selectively targets a dangerous pathogen without causing harm to beneficial bacteria. The findings could inform the development of new narrow-spectrum antibiotics for treating other types of infection.
With a breadth and depth of experience across academia, the pharmaceutical industry, technology, healthcare, and the financial sector, this latest cohort of trustees brings new skill sets and perspectives to the community.
In response to the Russian invasion of Ukraine on February 24, 2022, Rockefeller University President Richard P. Lifton today released the following statement: The Rockefeller University is a vibrant, international community. Our scientists, students, and staff come from all over the world, inclu...
Rockefeller’s Information Security team has implemented one of the most substantial upgrades in its history. As backend protections are strengthened, community members also have a critical role to play.
Increasingly, hospitalized patients contract infections that evade current antibiotics including colistin, long used as a last treatment option. The discovery of a new colistin variant might make it possible to outmaneuver these pathogens.
This year's scientific endeavors included multiple attacks on SARS-CoV-2—and a lot more. Here are the most memorable science stories to come out of Rockefeller labs in 2021, from the benefits of brown fat to the pitfalls of modern IVF screening techniques.